Date Posted – 20 May 2021 Accelagen, a Melbourne based Regulatory Affairs, Clinical Research and Development Organisation, has come from humble beginnings and grown into a highly successful, effective and committed Contract Research Organisation (CRO) working with…
Date Posted – 12 May 2021 From our CEO, Jeff Malone GAICD on the new budget… This new budget outlines a number of very welcome initiatives including continued and consistent support for the R&D tax incentive and investment into Biotech…
Date Posted – 17 May 2021 The Minister for Health has announced that Snoretox has won a Medical Research Future Fund (MRFF) 2021 Frontier Health and Medical Research Initiative Grant, securing a 1 Million dollar 12 month grant and…
Date Posted – 13 May 2021 A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what’s anticipated to be the second line of…
Date Posted – 13 May 2021 Four outstanding women have been recognised for their incredible work across Victoria’s health technology sector as Australia dealt with COVID-19 in 2020. Victoria’s medical and scientific communities made an important contribution to…
Date Posted – 3 May 2021 Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, and Patrys Limited (ASX: PAB), a therapeutic antibody development company, are pleased to announce a…
Date Posted – 27 April 2021 Adelaide-based Australian biotechnology company Sementis has appointed internationally-renowned Dr Anna Lavelle as an Independent Director. Dr Lavelle was named among the world’s 100 most influential people in global life sciences by Scientific…
Date Posted – 21 April 2021 The Victorian government is providing $50 million to “kickstart” domestic manufacturing of mRNA vaccine technology. It will take at least 12 months for any of the vaccines to be made in Australia,…
Date Posted – 19 April 2021 AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel medicines using its i-body platform is pleased to announce that the first cohort of healthy volunteers have received the first of three…
Date Posted – 8 April 2021 The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational, with the first patients to receive the non-invasive radiosurgery sharing their experiences. The Gamma…
Date Posted – 6 April 2021 Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the Asia Pacific region, is delighted to announce the appointment of Mr Peter Giannopoulos as the company’s new Chief Executive…
Date Posted – 26 March 2021 Date Published – 22 March 2021 First needle-free DNA-based COVID-19 candidate vaccine to be tested in Australia in a phase 1 trial in healthy subjects aged 18 to 75 years old •…